J&J Risperdal "Dear Doctor" Letter Minimizes Diabetes Risk, FDA Ad Division Says

The agency warning letter says J&J inappropriately claimed that Risperdal is safer than other atypical antipsychotics. The company is working with FDA to address the agency's concerns as quickly as possible.